Press Releases

Filters
November 9, 2021

Swiss-based Debiopharm co-invests in the future of cell therapies on a chip through the latest $25 million Series A round…

Read more
January 14, 2021

Nucleai and Debiopharm Launch Research Collaboration Utilizing Nucleai’s AI-Powered Biomarker Platform

Read more
September 9, 2020

Belgian scale-up Oncomfort raises €10 million in Series A funding co-led by Debiopharm and Crédit Mutuel Innovation to further develop…

Read more
July 7, 2020

Nucleai Secured $6.5m Series-A Initial Closing Led by Debiopharm to Advance Ai-Powered Precision Oncology Platform

Read more
May 26, 2020

Acquisition of Debiopharm’s Investment Portfolio Company Kaiku Health Broadens Patient Access to Digital Oncology Intervention

Read more
January 9, 2020

Novadiscovery raises series A financing to scale its in silico clinical trial platform – Debiopharm leads the round with EUR…

Read more
April 5, 2018

Kaiku Health raises €4.4 million series A financing to accelerate its digital therapeutics pipeline led by Debiopharm and Tesi

Read more
May 9, 2017

BC Platforms Closes USD $10 million Series B Financing led by Debiopharm and Tesi to accelerate knowledge platform development

Read more
March 7, 2017

Debiopharm Innovation Fund: the New Name and Investment Strategy of Debiopharm Diagnostics

Read more